The global pharmaceutical landscape is experiencing a monumental transformation, fueled by the newly enacted U.S. Biosecure Act. This pivotal legislation seeks to bolster national security by preventing U.S. companies from engaging with foreign biotech firms that pose risks through unauthorized data sharing and affiliations with adversarial military or